KFDA approves 26 Stillen generics

Dong-A Pharm’s Stillen, is unlikely to become a cash cow product as a total of 26 drug manufacturers, including Chong Kung Dang Pharmaceutical, Dongwha Pharm and Kwagdong, obtained a nod for Stillen generics from the Korea Food and Drug Administration.

CKDP already received the market authorization of Stillen generic on July 2008 and plans to launch it on the domestic market this year, altho...